Empowered Funds LLC Buys 76,255 Shares of Docusign Inc. $DOCU

Key Points

• Empowered Funds LLC increased its stake in Docusign Inc. by 270.1%, acquiring 76,255 additional shares to hold approximately $8.5 million worth of the company stock.
• Multiple hedge funds, including Caxton Associates LLP and Rise Advisors LLC, have also modified their positions in Docusign, with 77.64% of the stock now owned by institutional investors.
• Analysts have given mixed ratings for Docusign, with a consensus rating of "Hold" and an average target price of $94.14, while recent earnings exceeded expectations with revenue of $800.64 million.

Empowered Funds LLC grew its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 270.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 104,485 shares of the company's stock after buying an additional 76,255 shares during the quarter. Empowered Funds LLC owned 0.05% of Docusign worth $8,505,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Cetera Investment Advisers grew its holdings in Docusign by 11.8% during the 4th quarter. Cetera Investment Advisers now owns 50,329 shares of the company's stock worth $4,527,000 after acquiring an additional 5,302 shares during the last quarter. CoreCap Advisors LLC boosted its stake in shares of Docusign by 113.4% in the 4th quarter. CoreCap Advisors LLC now owns 2,044 shares of the company's stock valued at $184,000 after purchasing an additional 1,086 shares during the last quarter. Deutsche Bank AG boosted its stake in shares of Docusign by 26.3% in the 4th quarter. Deutsche Bank AG now owns 546,078 shares of the company's stock valued at $49,114,000 after purchasing an additional 113,608 shares during the last quarter. Ethic Inc. bought a new position in shares of Docusign in the 4th quarter valued at about $341,000. Finally, Focus Partners Wealth raised its position in shares of Docusign by 19.8% in the 4th quarter. Focus Partners Wealth now owns 11,063 shares of the company's stock valued at $995,000 after acquiring an additional 1,829 shares during the period. Institutional investors own 77.64% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on DOCU shares. JPMorgan Chase & Co. increased their price target on shares of Docusign from $77.00 to $80.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Morgan Stanley increased their price target on shares of Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research report on Monday. Royal Bank Of Canada raised their target price on shares of Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a report on Friday, September 5th. JMP Securities restated a "market outperform" rating and set a $124.00 target price on shares of Docusign in a report on Friday, September 5th. Finally, Wedbush dropped their target price on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a report on Thursday, June 12th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have assigned a Hold rating to the company's stock. According to data from MarketBeat, Docusign presently has a consensus rating of "Hold" and an average target price of $94.14.

Docusign Trading Down 0.1%

Shares of NASDAQ DOCU traded down $0.05 during midday trading on Friday, reaching $80.19. The company's stock had a trading volume of 2,170,380 shares, compared to its average volume of 3,118,836. Docusign Inc. has a fifty-two week low of $55.14 and a fifty-two week high of $107.86. The stock has a market capitalization of $16.13 billion, a price-to-earnings ratio of 60.29, a PEG ratio of 4.21 and a beta of 1.02. The stock has a 50 day simple moving average of $75.74 and a 200-day simple moving average of $79.25.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same period last year, the company earned $0.97 earnings per share. The firm's revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities analysts anticipate that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its Board of Directors has authorized a share repurchase program on Thursday, June 5th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 6.6% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Insider Activity

In other Docusign news, insider Robert Chatwani sold 22,875 shares of the business's stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total transaction of $1,710,821.25. Following the transaction, the insider owned 72,126 shares of the company's stock, valued at $5,394,303.54. The trade was a 24.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total value of $3,100,400.00. Following the transaction, the chief executive officer directly owned 143,983 shares in the company, valued at approximately $11,160,122.33. This trade represents a 21.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 79,899 shares of company stock valued at $6,090,570 over the last three months. Corporate insiders own 1.01% of the company's stock.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.